Pfizer Is Submitting Its COVID Vaccine For Emergency Authorization Today

Pfizer Is Submitting Its COVID Vaccine For Emergency Use Authorization Today

Companies Working On Coronavirus Vaccine
Jakub Porzycki/NurPhoto/Getty

As of today, Pfizer will be the first pharmaceutical company to ask the FDA for emergency use authorization for a vaccine

Let’s get one thing straight: The coronavirus pandemic is not over, and we’re likely still many months away from life returning to anything resembling pre-pandemic normalcy. However, there is some very good news on that front today. Pfizer, one of the first drug making companies to announce results from its clinical trials for a COVID vaccine, is submitting that vaccine to the FDA for emergency use authorization today.

Pfizer announced the move in a press release.

“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally,” Pfizer Chairman and CEO Dr. Albert Bourla said in the release. “Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential.”

Bourla continued, “We look forward to the upcoming Vaccines and Related Biological Products Advisory Committee discussion and continue to work closely with the FDA and regulatory authorities worldwide to secure authorization of our vaccine candidate as quickly as possible.”